This site is intended for healthcare professionals

XIENCE stent receives European CE Mark for one-month dual anti-platelet therapy (DAPT) for high bleeding risk patients. - Abbott

Read time: 1 mins
Last updated:7th Apr 2021
Published:7th Apr 2021
Condition: Coronary Artery Disease
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest